Dino A Rossi, Director at Krystal Biotech, sold KRYS on Aug 14, 2026
Data as of Oct 16
- Traded
- Aug 14, 2026
- Disclosed
- Aug 14, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
KRYS since disclosure
−4.7%
after the sale
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund
Change in closing price from Aug 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLDino A Rossi DirectorKRYS Krystal Biotech, Inc.$111Kdisclosed Aug 14 · filed the same day
- ▼ SELLDino A Rossi DirectorKRYS Krystal Biotech, Inc.$1.7Mdisclosed Aug 14 · filed the same day
- ▼ SELLDino A Rossi DirectorKRYS Krystal Biotech, Inc.$554Kdisclosed Aug 14 · filed the same day
- ▼ SELLDino A Rossi DirectorKRYS Krystal Biotech, Inc.$1Mdisclosed Aug 14 · filed the same day
- ▼ SELLDino A Rossi DirectorKRYS Krystal Biotech, Inc.$13.3Kdisclosed Aug 14 · filed the same day
- ▼ SELLDino A Rossi DirectorKRYS Krystal Biotech, Inc.$1.6Mdisclosed Aug 14 · filed the same day
- ▼ SELLDino A Rossi DirectorKRYS Krystal Biotech, Inc.$747Kdisclosed Aug 14 · filed the same day